Guidelines for diagnosis and treatment of glucocorticoid-induced osteoporosis / 中华内科杂志
Chinese Journal of Internal Medicine
; (12): 631-638, 2023.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-985972
Responsible library:
WPRO
ABSTRACT
Glucocorticoid-induced osteoporosis (GIOP) is a skeletal disease characterized by decreased bone strength and increased fracture risk associated with long-term glucocorticoid use. GIOP is the most common secondary osteoporosis that critically affects the quality of life of patients. Currently, the incidence of GIOP in China remains high, with insufficient awareness and lack of prevention and treatment norms. Therefore, the Chinese Rheumatology Association has established this standard based on domestic and international experience, with the aim of raising awareness of prevention and treatment among clinicians, guiding the standardized diagnosis and treatment of this disease, and improving the overall prognosis of patients with GIOP.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Osteoporosis
/
Quality of Life
/
Rheumatology
/
Bone Density
/
Incidence
/
Glucocorticoids
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Internal Medicine
Year:
2023
Document type:
Article